Medicaid Provider Spending

$1.09 trillion in Medicaid claims data, 2018–2024 · 617K+ providers

COMMUNITY ACTION CORPORATION OF SOUTH TEXAS

NPI: 1164868998 · KINGSVILLE, TX 78363 · Federally Qualified Health Center (FQHC) · NPI assigned 05/20/2013

$6.08M
Total Medicaid Paid
171,953
Total Claims
142,037
Beneficiaries
67
Codes Billed
2019-04
First Month
2024-12
Last Month

Provider Details

Authorized OfficialAWALT, ANN (EXECUTIVE DIRECTOR)
Parent OrganizationCOMMUNITY ACTION CORPORATION OF SOUTH TEXAS
NPI Enumeration Date05/20/2013

Related Entities

Other providers sharing the same authorized official: AWALT, ANN

ProviderCityStateTotal Paid
COMMUNITY ACTION CORPORATION OF SOUTH TEXAS ALICE TX $35.13M
COMMUNITY ACTION CORPORATION OF SOUTH TEXAS FALFURRIAS TX $4.97M
COMMUNITY ACTION CORPORATION OF SOUTH TEXAS BEEVILLE TX $3.24M
COMMUNITY ACTION CORPORATION OF SOUTH TEXAS ALICE TX $2.50M
COMMUNITY ACTION CORPORATION OF SOUTH TEXAS ALICE TX $689K
COMMUNITY ACTION CORPORATION OF SOUTH TEXAS MATHIS TX $582K
COMMUNITY ACTION CORPORATION OF SOUTH TEXAS SINTON TX $571K
COMMUNITY ACTION CORPORATION OF SOUTH TEXAS SINTON TX $242K
COMMUNITY ACTION CORPORATION OF SOUTH TEXAS BENAVIDES TX $119K

Monthly Spending Trend

Yearly Breakdown

YearClaimsTotal Paid
2019 63 $12K
2020 4,496 $235K
2021 36,455 $1.55M
2022 45,689 $1.58M
2023 50,034 $1.54M
2024 35,216 $1.17M

Billing Codes

CodeDescriptionClaimsBeneficiariesTotal Paid
T1015 Clinic visit/encounter, all-inclusive 30,616 21,913 $4.89M
99213 Office or other outpatient visit for the evaluation and management of an established patient, low complexity 18,028 14,872 $768K
D0999 Unspecified diagnostic procedure, by report 924 792 $159K
99214 Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity 2,821 2,313 $126K
99392 Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) 820 789 $36K
99393 Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) 742 711 $33K
99212 Office or other outpatient visit for the evaluation and management of an established patient, straightforward 658 622 $27K
99394 Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) 457 444 $22K
99391 Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) 195 193 $10K
99215 Prolong outpt/office vis 68 58 $3K
0001A 86 84 $2K
0002A 55 50 $2K
92552 3,249 3,091 $1K
D0120 Periodic oral evaluation - established patient 253 232 $666.58
0072A 13 13 $440.00
0071A 19 19 $200.00
90658 99 98 $193.78
96110 Developmental screening, with scoring and documentation, per standardized instrument 796 731 $147.59
87428 555 502 $50.25
D1206 Topical application of fluoride varnish 72 71 $45.67
90471 Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine 3,720 3,578 $16.41
87804 Infectious agent antigen detection by immunoassay; Influenza, each type 212 195 $0.33
D1120 Prophylaxis - child 27 27 $0.20
87426 Infectious agent antigen detection, SARS-CoV-2 (COVID-19) 102 101 $0.20
90472 Immunization administration, each additional vaccine (list separately) 1,357 1,304 $0.05
99173 3,439 3,243 $0.01
1159F 20,503 17,041 $0.01
90686 726 700 $0.01
2010F 12,543 10,505 $0.01
99050 114 95 $0.01
3028F 2,023 1,796 $0.00
1160F 20,038 16,643 $0.00
1033F 401 333 $0.00
3078F 405 339 $0.00
S5000 Prescription drug, generic 48 44 $0.00
1003F 226 190 $0.00
90756 67 67 $0.00
90670 127 122 $0.00
99051 29 25 $0.00
87880 Infectious agent antigen detection by immunoassay; Streptococcus, group A 17 17 $0.00
S0119 Ondansetron, oral, 4 mg (for circumstances falling under the medicare statute, use hcpcs q code) 42 39 $0.00
90633 12 12 $0.00
2001F 14,888 12,248 $0.00
3008F 18,707 15,503 $0.00
1170F 533 455 $0.00
1220F 3,090 2,683 $0.00
2000F 1,098 972 $0.00
87635 Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe 131 120 $0.00
1000F 1,242 1,014 $0.00
1126F 1,598 1,455 $0.00
36415 Collection of venous blood by venipuncture 839 791 $0.00
3037F 917 778 $0.00
J0696 Injection, ceftriaxone sodium, per 250 mg 35 29 $0.00
90651 39 36 $0.00
D1330 208 199 $0.00
0241U Neonatal screening for hereditary disorders, genomic sequence analysis panel 385 374 $0.00
90688 326 319 $0.00
96372 Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular 34 28 $0.00
3074F 592 487 $0.00
1125F 201 181 $0.00
D0601 137 135 $0.00
3079F 104 90 $0.00
87807 32 31 $0.00
99406 47 38 $0.00
J2001 Injection, lidocaine hcl for intravenous infusion, 10 mg 35 29 $0.00
1036F 18 15 $0.00
36416 13 13 $0.00